Cetrotide (2020 — supply status, manufacturers & alternatives

Cetrotide (2020

ATC H01CC02

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Controlled substance
Active ingredient (INN)	Cetrotide (2020
ATC level 5	H01CC02
ATC level 4	H01CC
Therapeutic category	Auto-created by Health Canada — Recalls and Safety Alerts scraper

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Recalls official enforcement reports

🇨🇦

Cetrotide (2020

Drugs and health products · July 2020

Class Idetails ↗

🇨🇦

Cetrotide (Cetrorelix for Injection

Marketed health products · May 2013

Class ?details ↗

🇨🇦

Cetrotide (Cetrorelix for Injection

Marketed health products · May 2013

Class ?details ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.